BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33109238)

  • 1. Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study.
    Aso S; Navarro-Martin A; Castillo R; Padrones S; Castillo E; Montes A; Martínez JI; Cubero N; López R; Rodríguez L; Palmero R; Manresa F; Guerrero T; Molina M
    Radiat Oncol; 2020 Oct; 15(1):246. PubMed ID: 33109238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.
    Lopez Guerra JL; Gomez D; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1573-9. PubMed ID: 22768989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer.
    Torre-Bouscoulet L; Muñoz-Montaño WR; Martínez-Briseño D; Lozano-Ruiz FJ; Fernández-Plata R; Beck-Magaña JA; García-Sancho C; Guzmán-Barragán A; Vergara E; Blake-Cerda M; Gochicoa-Rangel L; Maldonado F; Arroyo-Hernández M; Arrieta O
    Respir Res; 2018 Apr; 19(1):72. PubMed ID: 29690880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
    Rancati T; Ceresoli GL; Gagliardi G; Schipani S; Cattaneo GM
    Radiother Oncol; 2003 Jun; 67(3):275-83. PubMed ID: 12865175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis.
    Szejniuk WM; Nielsen MS; Takács-Szabó Z; Pawlowski J; Al-Saadi SS; Maidas P; Bøgsted M; McCulloch T; Frøkjær JB; Falkmer UG; Røe OD
    Radiat Oncol; 2021 Jul; 16(1):131. PubMed ID: 34266462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
    Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
    Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer.
    Kimura T; Doi Y; Nakashima T; Imano N; Kawabata H; Nishibuchi I; Okabe T; Kenjo M; Ozawa S; Murakami Y; Nagata Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):778-87. PubMed ID: 26530746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
    Tsujino K; Hashimoto T; Shimada T; Yoden E; Fujii O; Ota Y; Satouchi M; Negoro S; Adachi S; Soejima T
    J Thorac Oncol; 2014 Jul; 9(7):983-990. PubMed ID: 24922010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
    Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients.
    Saha A; Beasley M; Hatton N; Dickinson P; Franks K; Clarke K; Jain P; Teo M; Murray P; Lilley J
    Radiother Oncol; 2021 Mar; 156():153-159. PubMed ID: 33333139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric factors used for thoracic X-ray radiotherapy are not predictive of the occurrence of radiation pneumonitis after carbon-ion radiotherapy.
    Koto M; Tsujii H; Yamamoto N; Nishimura H; Yamada S; Miyamoto T
    Tohoku J Exp Med; 2007 Oct; 213(2):149-56. PubMed ID: 17917408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity.
    Bensenane R; Helfre S; Cao K; Carton M; Champion L; Girard N; Glorion M; Vieira T; Waissi W; Crehange G; Beddok A
    Cancer Treat Rev; 2024 Mar; 124():102684. PubMed ID: 38278078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.
    Robnett TJ; Machtay M; Vines EF; McKenna MG; Algazy KM; McKenna WG
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):89-94. PubMed ID: 10924976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images.
    Yamamoto T; Kadoya N; Sato Y; Matsushita H; Umezawa R; Kubozono M; Ishikawa Y; Kozumi M; Takahashi N; Morishita Y; Katagiri Y; Sato K; Ito K; Takeda K; Jingu K
    Clin Lung Cancer; 2018 Jan; 19(1):e85-e90. PubMed ID: 28655592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer.
    Moreno M; Aristu J; Ramos LI; Arbea L; López-Picazo JM; Cambeiro M; Martínez-Monge R
    Clin Transl Oncol; 2007 Sep; 9(9):596-602. PubMed ID: 17921108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy.
    Dang J; Li G; Zang S; Zhang S; Yao L
    Radiat Oncol; 2014 Jul; 9():172. PubMed ID: 25074618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.
    Mehta V
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):5-24. PubMed ID: 15963660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.
    Alharbi M; Janssen S; Golpon H; Bremer M; Henkenberens C
    Radiat Oncol; 2017 Nov; 12(1):165. PubMed ID: 29096667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.